Cell therapy for intervertebral disc repair: Clinical perspective
Low back pain is the main cause of disability and is associated with intervertebral disc degeneration. Contemporary treatments are limited to palliative therapeutics or aggressive surgical interventions; however, current advancements in cell therapy offer to fill this breach. Clinical data suggest t...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-04-01
|
Series: | Journal of Orthopaedic Translation |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214031X16302881 |
id |
doaj-200194418a7c4a7d875a777b99ffd037 |
---|---|
record_format |
Article |
spelling |
doaj-200194418a7c4a7d875a777b99ffd0372020-11-24T21:43:43ZengElsevierJournal of Orthopaedic Translation2214-031X2017-04-019C81810.1016/j.jot.2017.02.002Cell therapy for intervertebral disc repair: Clinical perspectiveDaisuke SakaiJordy ScholLow back pain is the main cause of disability and is associated with intervertebral disc degeneration. Contemporary treatments are limited to palliative therapeutics or aggressive surgical interventions; however, current advancements in cell therapy offer to fill this breach. Clinical data suggest that cell transplantation can accomplish pain relief without any observed adverse effects. Despite a large variety of preclinical studies and preliminary clinical investigations, controversy remains on the optimal cell type and transplantation strategies. The translational potential of this article lies in the aim to update on the current state of intervertebral disc cell therapy and to identify current obstacles.http://www.sciencedirect.com/science/article/pii/S2214031X16302881cell therapyclinical trialintervertebral disc |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Daisuke Sakai Jordy Schol |
spellingShingle |
Daisuke Sakai Jordy Schol Cell therapy for intervertebral disc repair: Clinical perspective Journal of Orthopaedic Translation cell therapy clinical trial intervertebral disc |
author_facet |
Daisuke Sakai Jordy Schol |
author_sort |
Daisuke Sakai |
title |
Cell therapy for intervertebral disc repair: Clinical perspective |
title_short |
Cell therapy for intervertebral disc repair: Clinical perspective |
title_full |
Cell therapy for intervertebral disc repair: Clinical perspective |
title_fullStr |
Cell therapy for intervertebral disc repair: Clinical perspective |
title_full_unstemmed |
Cell therapy for intervertebral disc repair: Clinical perspective |
title_sort |
cell therapy for intervertebral disc repair: clinical perspective |
publisher |
Elsevier |
series |
Journal of Orthopaedic Translation |
issn |
2214-031X |
publishDate |
2017-04-01 |
description |
Low back pain is the main cause of disability and is associated with intervertebral disc degeneration. Contemporary treatments are limited to palliative therapeutics or aggressive surgical interventions; however, current advancements in cell therapy offer to fill this breach. Clinical data suggest that cell transplantation can accomplish pain relief without any observed adverse effects. Despite a large variety of preclinical studies and preliminary clinical investigations, controversy remains on the optimal cell type and transplantation strategies. The translational potential of this article lies in the aim to update on the current state of intervertebral disc cell therapy and to identify current obstacles. |
topic |
cell therapy clinical trial intervertebral disc |
url |
http://www.sciencedirect.com/science/article/pii/S2214031X16302881 |
work_keys_str_mv |
AT daisukesakai celltherapyforintervertebraldiscrepairclinicalperspective AT jordyschol celltherapyforintervertebraldiscrepairclinicalperspective |
_version_ |
1725912349168107520 |